Details

Autor(en) / Beteiligte

• Darko, Delese A
• Seaneke, Seth K
• Sabblah, George T
• Ashie, Adela
• Asamoa-Amoakohene, Abena
• Ewudzie, Jeremiah S
• Asa-Eck, Theodora
• Agyei-Kwame, Ernest
• Dwamena, Felicia
• Mensah, Josephine
• Boateng, Jennifer

Titel

Preliminary findings from stimulated spontaneous reporting of adverse drug reactions during COVID-19 pandemic: an experience from Ghana

Ist Teil von

• Ghana medical journal, 2020-12, Vol.54 (4 Suppl), p.62-70

Ort / Verlag

Ghana: Ghana Medical Association

Erscheinungsjahr

2020

Quelle

MEDLINE

Beschreibungen/Notizen

• The novel coronavirus disease 2019 (COVID-19) is an ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There is limited information on the safety of drugs used for the treatment of COVID-19. Objective of this study is to describe the pattern of stimulated spontaneous adverse drug reaction (ADR) reports received from healthcare professionals for SARS-CoV-2 positive patients in Ghana and lessons learnt particularly for low- and middle-income countries. This is a study of individual case safety reports (ICSRs) received from healthcare professionals between 1 April 2020 to 31 July 2020 in SARS-CoV-2 positive patients in Ghana. The ICSRs were retrieved from the SafetyWatch System and descriptive statistics used to describe the ADRs by System Organ Classification and Preferred Term. Information was received from 40 COVID-19 Treatment Centres across the country with 9 centres submitting a total of 53 ICSRs containing 101 ADRs; approximately two ADRs per ICSR. Females accounted for 29(54.7%) of the ICSRs and males 24(45.3%). Newly reported ADRs of interest were one report each of tremor for doxycycline; scrotal pain, dyspnoea, gait disturbances and dysgeusia for chloroquine; and dry throat, hyperhidrosis, restlessness and micturition frequency increased for hydroxychloroquine. A strong spontaneous system with the availability of focal persons at the Treatment Centres played a key role in reporting ADRs during the pandemic. This is the first experience with spontaneous reporting during COVID-19 pandemic in Ghana. The profile of most of the ADRs reported appears consistent with what is expected from the summary of product characteristics. A study with a larger sample size with well-defined denominator in future studies is paramount in determining the relative risk of these medications in SARS-CoV-2 positive patients. None declared.